XORTX Therapeutics Inc. (XRTX) - Earnings growth in current year

Corporate emblem and logo of XORTX Therapeutics Inc. (XRTX)

Clinical progress of xanthine oxidase inhibitors and interest from Big Pharma are driving growth for XORTX Therapeutics Inc. (XRTX), while the YoY earnings per share growth rate on the GURU.Markets chart demonstrates current efficiency, where the 0.00 indicator determines the metric's magnitude. Monopoly pricing power in the therapy of rare kidney pathologies is complemented by the stability of the scientific core and the strategic hiring of regulatory experts.

XRTX - XORTX Therapeutics Inc. Earnings growth in current year over the range 07/04/2022 - 11/17/2026

Analytical breakdowns and data insights for company XORTX Corp (XRTX)

Basic company analysis:XORTX Therapeutics Inc. (XRTX)
Brand item of XORTX

The absence of capital expenditures due to the outsourcing of production and testing provides XORTX Therapeutics Inc. (XRTX) with high operational flexibility. This strategy directly impacts the calculation base of the metric measuring the percentage change in net income per share relative to the previous year. This indicator reflects the efficiency of the business's adaptation to current monetary policy, which clearly demonstrates a comparable year-over-year growth rate in earnings per share.

Key competitors

Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Expected net earnings per share growth this year Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net earnings per share growth this year|Net earnings per share growth this year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth in current year|Earnings per share growth rate in current year Immunome Corp IMNM|Net earnings per share growth this year GOSS (Gossamer Corp)|KALV (KalVista Corp) - Earnings per share increase in current year|Earnings growth in current year SEPN (septerna.com)|Earnings growth in current year pieris.com PVLA|SVRA: Net earnings per share growth this year|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth this year|ANAB: Earnings growth in current year|Astria Corp (ATXS) - Earnings growth in current year|Earnings per share growth in current year enGene|Earnings growth in current year RAPT Therapeutics|Earnings growth in current year JBIO|ACRS: Earnings per share trend in current year|Earnings growth in current year KYTX (kyvernatx.com)|TLSA - Net earnings per share growth this year|CABA - Earnings per share growth in current year|Ventyx Biosciences (VTYX) - Net earnings per share growth this year|Theratechnologies, Inc. (THTX) - Earnings per share growth in current year|Net earnings per share growth this year Avalo Therapeutics, Inc.|ELDN (Eledon Pharmaceuticals, Inc) - Earnings growth in current year|Agenus, Inc (AGEN) - Expected net earnings per share growth this year|Earnings growth in current year CLYM|ZURA (Zura Bio Limited) - Earnings per share increase in current year|Earnings per share growth in current year aTyr Pharma ATYR|ADAG - Net earnings per share growth this year|IMA - Earnings per share growth in current year|Shattuck Labs - Net earnings per one share growth for the current year|EQ: Earnings growth in current year|Earnings per share trend in current year CNTB (Connect Biopharma Holdings)|Net earnings per share growth this year IMUX|ATRA (atarabio.com) - Net earnings per one share growth for the current year|Earnings growth in current year IFRX|Earnings growth in current year X4 Pharma (XFOR)|Adicet Bio Inc. - Net earnings per share growth this year|Earnings growth in current year celularity.com CELU|INMB: Net earnings per share growth this year|BRNS: Earnings per share growth in current year|KZR: Earnings growth in current year|SAB Biotherapeutics Inc - Earnings per share increase in current year|AKTX (Akari Therapeutics, Plc) - Earnings growth in current year|ENLV: Earnings per share increase in current year|Earnings per share growth in current year Q32 Bio (QTTB)|Net earnings per share growth this year GeoVax Labs GOVX|Earnings growth in current year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Earnings per share growth rate in current year|CARM: Net earnings per share growth this year|XTL Biopharmaceuticals (XTLB) - Net earnings per share growth this year|BOLT: Earnings growth in current year|Net earnings per share growth this year HCW Biologics Inc.|Earnings per share growth in current year aptevotherapeutics.com|AIM: Earnings per share increase in current year|Earnings per share growth in current year aditxt.com (ADTX)|GRI - Earnings per share growth rate in current year|Earnings growth in current year HIND (Vyome Therapeutics)|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year